Literature DB >> 25398732

Considerations on an approach for establishing a framework for bioactive food components.

Kathleen Ellwood1, Douglas A Balentine2, Johanna T Dwyer3, John W Erdman4, P Courtney Gaine5, Catherine L Kwik-Uribe6.   

Abstract

Bioactive food components have shown potential health benefits for more than a decade. Currently there are no recommended levels of intake [i.e., Dietary Reference Intakes (DRIs)] as there are for nutrients and fiber. DRIs for essential nutrients were based on requirements for each specific nutrient to maintain normal physiologic or biochemical function and to prevent signs of deficiency and adverse clinical effects. They were later expanded to include criteria for reducing the risk of chronic degenerative diseases for some nutrients. There are many challenges for establishing recommendations for intakes of nonessential food components. Although some nonessential food components have shown health benefits and are safe, validated biomarkers of disease risk reduction are lacking for many. Biomarkers of intake (exposure) are limited in number, especially because the bioactive compounds responsible for beneficial effects have not yet been identified or are unknown. Furthermore, given this lack of characterization of composition in a variety of foods, it is difficult to ascertain intakes of nonessential food components, especially with the use of food-frequency questionnaires designed for estimating intakes of nutrients. Various intermediary markers that may predict disease outcome have been used as functional criteria in the DRI process. However, few validated surrogate endpoints of chronic disease risk exist. Nonvalidated intermediary biomarkers of risk may possibly predict clinical outcomes, but more research is needed to confirm the associations between cause and effect. One criterion for establishing acceptable intermediary outcome indicators may be the maintenance of normal physiologic function throughout adulthood, which presumably would lead to reduced chronic disease risk. Multiple biomarkers of outcomes that demonstrate the same health benefit may also be helpful. It would be beneficial to continue to refine the process of setting DRIs by convening a workshop on establishing a framework for nonessential food components that would take into consideration intermediary biomarkers indicative of optimal health.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398732      PMCID: PMC4224206          DOI: 10.3945/an.114.006312

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  11 in total

1.  A practical approach to evidence grading.

Authors:  N Greer; G Mosser; G Logan; G W Halaas
Journal:  Jt Comm J Qual Improv       Date:  2000-12

Review 2.  Food and nutrient exposures: what to consider when evaluating epidemiologic evidence.

Authors:  C T Sempos; K Liu; N D Ernst
Journal:  Am J Clin Nutr       Date:  1999-06       Impact factor: 7.045

Review 3.  Methodologic and statistical considerations regarding use of biomarkers of nutritional exposure in epidemiology.

Authors:  James R Marshall
Journal:  J Nutr       Date:  2003-03       Impact factor: 4.798

4.  Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Authors:  Paula Trumbo; Sandra Schlicker; Allison A Yates; Mary Poos
Journal:  J Am Diet Assoc       Date:  2002-11

5.  U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011.

Authors:  Shelley McGuire
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

6.  Dietary reference intakes for vitamin D: justification for a review of the 1997 values.

Authors:  Elizabeth A Yetley; Danielle Brulé; Margaret C Cheney; Cindy D Davis; Krista A Esslinger; Peter W F Fischer; Karl E Friedl; Linda S Greene-Finestone; Patricia M Guenther; David M Klurfeld; Mary R L'Abbe; Kathryn Y McMurry; Pamela E Starke-Reed; Paula R Trumbo
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

7.  Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC.

Authors:  John W Erdman; Douglas Balentine; Lenore Arab; Gary Beecher; Johanna T Dwyer; John Folts; James Harnly; Peter Hollman; Carl L Keen; G Mazza; Mark Messina; Augustin Scalbert; Joseph Vita; Gary Williamson; Jerrilynn Burrowes
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

8.  Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials.

Authors:  Lee Hooper; Paul A Kroon; Eric B Rimm; Jeffrey S Cohn; Ian Harvey; Kathryn A Le Cornu; Jonathan J Ryder; Wendy L Hall; Aedín Cassidy
Journal:  Am J Clin Nutr       Date:  2008-07       Impact factor: 7.045

9.  Nutrient reference values for bioactives: new approaches needed? A conference report.

Authors:  Hans Konrad Biesalski; John W Erdman; John Hathcock; Kathleen Ellwood; Stephen Beatty; Elizabeth Johnson; Roberto Marchioli; Lotte Lauritzen; Harry B Rice; Andrew Shao; James C Griffiths
Journal:  Eur J Nutr       Date:  2013-04       Impact factor: 5.614

Review 10.  Exploring the benefits and challenges of establishing a DRI-like process for bioactives.

Authors:  Joanne R Lupton; Stephanie A Atkinson; Namsoo Chang; Cesar G Fraga; Joseph Levy; Mark Messina; David P Richardson; Ben van Ommen; Yuexin Yang; James C Griffiths; John Hathcock
Journal:  Eur J Nutr       Date:  2014-04       Impact factor: 5.614

View more
  7 in total

Review 1.  Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group.

Authors:  Elizabeth A Yetley; Amanda J MacFarlane; Linda S Greene-Finestone; Cutberto Garza; Jamy D Ard; Stephanie A Atkinson; Dennis M Bier; Alicia L Carriquiry; William R Harlan; Dale Hattis; Janet C King; Daniel Krewski; Deborah L O'Connor; Ross L Prentice; Joseph V Rodricks; George A Wells
Journal:  Am J Clin Nutr       Date:  2016-12-07       Impact factor: 7.045

Review 2.  History of Nutrition: The Long Road Leading to the Dietary Reference Intakes for the United States and Canada.

Authors:  Suzanne P Murphy; Allison A Yates; Stephanie A Atkinson; Susan I Barr; Johanna Dwyer
Journal:  Adv Nutr       Date:  2016-01       Impact factor: 8.701

3.  Scientific rigor and credibility in the nutrition research landscape.

Authors:  Cynthia M Kroeger; Cutberto Garza; Christopher J Lynch; Esther Myers; Sylvia Rowe; Barbara O Schneeman; Arya M Sharma; David B Allison
Journal:  Am J Clin Nutr       Date:  2018-03-01       Impact factor: 7.045

4.  Improving the estimation of flavonoid intake for study of health outcomes.

Authors:  Julia J Peterson; Johanna T Dwyer; Paul F Jacques; Marjorie L McCullough
Journal:  Nutr Rev       Date:  2015-06-16       Impact factor: 7.110

5.  Perspective: Structure-Function Claims on Infant Formula.

Authors:  John C Wallingford
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

Review 6.  Terms and nomenclature used for plant-derived components in nutrition and related research: efforts toward harmonization.

Authors:  Jan Frank; Naomi K Fukagawa; Anna R Bilia; Elizabeth J Johnson; Oran Kwon; Vish Prakash; Teruo Miyazawa; Michael N Clifford; Colin D Kay; Alan Crozier; John W Erdman; Andrew Shao; Gary Williamson
Journal:  Nutr Rev       Date:  2020-06-01       Impact factor: 7.110

7.  Is cytotoxicity a determinant of the different in vitro and in vivo effects of bioactives?

Authors:  Mattia Di Nunzio; Veronica Valli; Lidia Tomás-Cobos; Teresa Tomás-Chisbert; Lucía Murgui-Bosch; Francesca Danesi; Alessandra Bordoni
Journal:  BMC Complement Altern Med       Date:  2017-09-07       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.